Setup
Pharmaceutical advances are expanding, with some exciting new drugs already on the market and others ready to emerge from the pipeline. These therapeutics offer fresh hope for combatting perilous infections, such as multi-drug resistant tuberculosis, and neglected tropical diseases, which affect more than one billion people every year. But it takes more than product development to reduce these global threats; it also requires policies to scale up distribution and reach the hardest to serve. What cutting-edge therapies are being added to the global arsenal? How do we put them in the right hands at the right price?
Speakers
-
Anthony FauciDirector of the National Institute of Allergy and Infectious Diseases -
Ellen AglerCEO, END Fund -
Susan SilbermannPresident and General Manager, Pfizer Vaccines, Pfizer (Festival Under... -
Helen BranswellSenior Writer, Global Health, STAT -
Adrian ThomasVP of Global Public Health, Johnson & Johnson (Festival Underwriter)
Explore More
Health
If you're fully vaccinated, are you protected from COVID-19? Will we need booster shots? What's the best way to keep children safe as they return to school? Infectious disease...
From blockchain to back to school and virus-hunting to bridging divides, speakers at the 2021 Aspen Ideas Festival addressed issues in a new kind of world—one touched, and cha...
Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the wor...
Faced with the COVID-19 pandemic, the healthcare industry had to quickly adapt to confront the rapidly evolving challenges facing its patients, customers, and employees. Learn...
As new public health threats brew, we need to ensure there is capacity within our health systems to serve the people of this country. There is a strong business case for readi...